Key Highlights
- Quantum Computing (QUBT) is set to announce its Q4 FY25 financial results on March 2, 2026.
- Market analysts anticipate a loss of $0.02 per share, a significant improvement from the $0.47 loss reported a year earlier.
- Revenue is projected to hit $390K, rising from the $62K recorded in Q4 2024.
- The stock price dropped 8.4% on February 27, falling below its 50-day and 200-day moving averages.
- Options markets are anticipating a potential price swing of 14.05% following the earnings report.
Quantum Computing Inc. is scheduled to release its fourth-quarter fiscal 2025 results on Monday, March 2, 2026. The company’s stock has struggled recently, declining 8.4% on February 27 to close at $8.278.
Trading volume for that day was approximately 3.37 million shares, which is roughly 78% lower than the average daily volume of 15 million. While a low-volume sell-off can indicate weak conviction, it is only one piece of the puzzle.
The stock is currently trading under its 50-day moving average of $10.35 and its 200-day moving average of $13.70. Over the last 12 months, however, the stock has risen more than 39%, largely due to investor interest in its photonic technology.
Wall Street analysts expect a loss of $0.02 per share for the fourth quarter of 2025. This represents a sharp narrowing of the $0.47 per share loss reported during the same period last year.
Revenue forecasts are set at $390K, compared to the $62K generated in Q4 2024. While these totals are relatively small, analysts are closely monitoring the company’s growth direction.
Spotlight on Luminar Acquisition
A major point of discussion for the upcoming call will be the company’s $110 million all-cash acquisition of Luminar Semiconductor Inc., formerly a part of Luminar Technologies. The acquisition is intended to give QUBT greater control over its technology stack and move it toward consistent revenue generation.
Investors will be looking for updates regarding chip manufacturing timelines, order fulfillment progress, and any early signs of revenue growth stemming from the deal.
Reductions in Analyst Price Targets
Analyst outlooks remain varied. Max Michaelis of Lake Street maintained a Buy rating but lowered his price target from $24 to $16, which still suggests a potential upside of about 77% from current prices.
Ascendiant Capital Markets also reduced its target from $40 to $25 while keeping a Buy rating. On the more conservative side, Wedbush started coverage with a Neutral rating and a $12 target, while Cantor Fitzgerald reiterated a Neutral rating with a $15 target.
Rosenblatt Securities began coverage in January with a Buy rating and a $22 price target. Overall, the consensus is a Moderate Buy, with one Strong Buy, two Buys, two Holds, and one Sell among analysts.
The average price target for the group is $18.00, representing a potential 99% increase from the stock’s price on February 27.
QUBT has a beta of 3.44, suggesting high volatility relative to the broader market. Its market capitalization is approximately $1.83 billion, and its P/E ratio is -13.40, reflecting its current lack of profitability.
Company insiders own 19.3% of the firm. COO Milan Begliarbekov sold 2,860 shares on January 7 at $11.85 per share, decreasing his stake by roughly 10.55%. Institutional ownership is currently low at 4.26%.
Options traders are pricing in a potential move of 14.05% in either direction following the earnings announcement.
The Q4 FY25 results will be released before the market opens on March 2, 2026.